annual CAPEX:
N/ASummary
- XENE annual capital expenditures is not available.
Performance
XENE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly CAPEX:
$43.00K-$740.00K(-94.51%)Summary
- As of today (July 1, 2025), XENE quarterly capital expenditures is $43.00 thousand, with the most recent change of -$740.00 thousand (-94.51%) on March 31, 2025.
- Over the past year, XENE quarterly CAPEX has dropped by -$145.00 thousand (-77.13%).
- XENE quarterly CAPEX is now -98.05% below its all-time high of $2.21 million, reached on March 31, 2023.
Performance
XENE quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$2.93M-$145.00K(-4.72%)Summary
- As of today (July 1, 2025), XENE TTM capital expenditures is $2.93 million, with the most recent change of -$145.00 thousand (-4.72%) on March 31, 2025.
- Over the past year, XENE TTM CAPEX has dropped by -$669.00 thousand (-18.59%).
- XENE TTM CAPEX is now -59.81% below its all-time high of $7.29 million, reached on September 30, 2023.
Performance
XENE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XENE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -77.1% | -18.6% |
| 3 y3 years | - | -79.7% | +57.7% |
| 5 y5 years | - | -93.3% | +76.9% |
XENE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.0% | at low | -59.8% | +96.3% | ||
| 5 y | 5-year | -98.0% | at low | -59.8% | +96.3% | ||
| alltime | all time | -98.0% | +207.1% | -59.8% | +950.2% |
XENE CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $43.00K(-94.5%) | $2.93M(-4.7%) |
| Dec 2024 | - | $783.00K(+32.7%) | $3.08M(+29.7%) |
| Sep 2024 | - | $590.00K(-61.0%) | $2.37M(-20.5%) |
| Jun 2024 | - | $1.51M(+705.3%) | $2.98M(-17.2%) |
| Mar 2024 | - | $188.00K(+141.0%) | $3.60M(-35.9%) |
| Dec 2023 | - | $78.00K(-93.5%) | $5.62M(-23.0%) |
| Sep 2023 | - | $1.20M(-43.7%) | $7.29M(+12.6%) |
| Jun 2023 | - | $2.13M(-3.3%) | $6.48M(+32.5%) |
| Mar 2023 | - | $2.21M(+25.9%) | $4.89M(+68.9%) |
| Dec 2022 | $2.89M(+41.2%) | $1.75M(+353.9%) | $2.89M(+74.8%) |
| Sep 2022 | - | $386.00K(-29.0%) | $1.66M(+10.9%) |
| Jun 2022 | - | $544.00K(+156.6%) | $1.49M(-19.6%) |
| Mar 2022 | - | $212.00K(-58.8%) | $1.86M(-9.4%) |
| Dec 2021 | $2.05M(-22.3%) | $514.00K(+130.5%) | $2.05M(-13.3%) |
| Sep 2021 | - | $223.00K(-75.5%) | $2.36M(-19.4%) |
| Jun 2021 | - | $909.00K(+125.0%) | $2.93M(+22.6%) |
| Mar 2021 | - | $404.00K(-51.2%) | $2.39M(-9.2%) |
| Dec 2020 | $2.64M(+112.7%) | $828.00K(+4.4%) | $2.64M(+9.7%) |
| Sep 2020 | - | $793.00K(+114.9%) | $2.40M(+45.2%) |
| Jun 2020 | - | $369.00K(-43.0%) | $1.66M(+6.7%) |
| Mar 2020 | - | $647.00K(+8.7%) | $1.55M(+25.2%) |
| Dec 2019 | $1.24M | $595.00K(+1222.2%) | $1.24M(+52.1%) |
| Sep 2019 | - | $45.00K(-83.0%) | $815.00K(+3.3%) |
| Jun 2019 | - | $265.00K(-20.9%) | $789.00K(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $335.00K(+97.1%) | $661.00K(+30.4%) |
| Dec 2018 | $507.00K(+61.0%) | $170.00K(+794.7%) | $507.00K(+26.8%) |
| Sep 2018 | - | $19.00K(-86.1%) | $400.00K(+1.3%) |
| Jun 2018 | - | $137.00K(-24.3%) | $395.00K(+10.0%) |
| Mar 2018 | - | $181.00K(+187.3%) | $359.00K(+14.0%) |
| Dec 2017 | $315.00K(+12.9%) | $63.00K(+350.0%) | $315.00K(+12.5%) |
| Sep 2017 | - | $14.00K(-86.1%) | $280.00K(-10.3%) |
| Jun 2017 | - | $101.00K(-26.3%) | $312.00K(-6.3%) |
| Mar 2017 | - | $137.00K(+389.3%) | $333.00K(+19.4%) |
| Dec 2016 | $279.00K(-49.4%) | $28.00K(-39.1%) | $279.00K(-29.2%) |
| Sep 2016 | - | $46.00K(-62.3%) | $394.00K(-30.4%) |
| Jun 2016 | - | $122.00K(+47.0%) | $566.00K(+2.9%) |
| Mar 2016 | - | $83.00K(-42.0%) | $550.00K(-0.2%) |
| Dec 2015 | $551.00K(-64.0%) | $143.00K(-34.4%) | $551.00K(-53.5%) |
| Sep 2015 | - | $218.00K(+105.7%) | $1.18M(-3.1%) |
| Jun 2015 | - | $106.00K(+26.2%) | $1.22M(+7.9%) |
| Mar 2015 | - | $84.00K(-89.2%) | $1.13M(-25.9%) |
| Dec 2014 | $1.53M(+880.1%) | $776.00K(+203.1%) | $1.53M(+103.1%) |
| Sep 2014 | - | $256.00K(+1405.9%) | $753.00K(+51.5%) |
| Jun 2014 | - | $17.00K(-96.5%) | $497.00K(+3.5%) |
| Mar 2014 | - | $480.00K | $480.00K |
| Dec 2013 | $156.00K(-70.3%) | - | - |
| Dec 2012 | $526.00K(+81.4%) | - | - |
| Dec 2011 | $290.00K | - | - |
FAQ
- What is the all time high annual CAPEX for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Xenon Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM CAPEX year-on-year change?
What is the all time high annual CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual capital expenditures is $2.89M
What is Xenon Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of XENE is $43.00K
What is the all time high quarterly CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly capital expenditures is $2.21M
What is Xenon Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, XENE quarterly capital expenditures has changed by -$145.00K (-77.13%)
What is Xenon Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of XENE is $2.93M
What is the all time high TTM CAPEX for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM capital expenditures is $7.29M
What is Xenon Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, XENE TTM capital expenditures has changed by -$669.00K (-18.59%)